Drugtestpanels can be highly customizable, depending on the testing laboratory,and may fit various and specific requirements from an employer. It is also importantto keep in mind that all drugs and cutoffs included in any drug test panel maybe subject to state laws and federal regulations such as the U.S. Department ofTransportation.
Drug testing statelaws vary across the country. While many states permit all types of drugtesting, some states have unique requirements and limitations. For instance,Maryland only allows hair specimens to be used for pre-employmentdrug testing and Vermont prohibits the use of oral fluid drug testing.
Drug testing laws are complex, inconsistent, and are constantly changing. Take marijuana, for instance. Today, 33 states and Washington, D.C. have comprehensive medical marijuana laws and 9 states and Washington, D.C., have recreational marijuana laws. Although companies turn to drug-free workplace programs to help keep employees safe and productive, many companies have questions about workplace drug testing policies and how marijuana legislation may impact those programs.
In the past year, Quest Diagnostics examined the analytics of specimens tested by our laboratories to gain a more thorough understanding of how and why companies drug test. The DTI Industry Insights offers employers in-depth information about which industries experience higher drug positivity, which may ultimately affect workplace safety. The analysis provides industry-specific insights based on objective lab data identifying the presence of several drugs including marijuana, amphetamines, cocaine, and opiates across a nationally representative workforce population.
Selecting the right drug test panel foryour workplace drug testing program can be complicated. To make it simpler, contacta Quest Diagnostics representative for more information about our drug testingpanels.
Carly Vandergriendt is a writer, translator, and educator based in Montreal, Canada. She holds a BSc in psychology and an MFA in creative writing. To keep up with Carly, visit her website , connect with her on LinkedIn, or follow her on Twitter.
S. Srakocic spent several years working in healthcare before making a major change and shifting to freelance writing. Focusing her writing career on healthcare and education allows her to translate her previous experience and create articles that are both accessible and informative. Her work has appeared in a growing list of publications of all sizes. You can find out more on her website.
Dr. Jill Seladi-Schulman is currently a freelance medical writer and was previously a project setup manager for clinical trials. She specializes in microbiology and infectious disease, having written her dissertation on influenza virus morphology. Dr. Seladi-Schulman has publications in peer-reviewed journals. She also has had her work featured on the cover of the Journal of Virology.
If your current or prospective employer asks you to take a drug test, you might be required by law to take it. Your hiring or continued employment might be contingent on a pass. However, this depends on the laws in your state.
If the second screening is positive, a medical review officer might speak to you to find out whether you have an acceptable medical reason for the result. At this point, the results may be shared with your employer.
(a) As a laboratory, you must use the cutoff concentrations displayed in the following table for initial and confirmatory drug tests. All cutoff concentrations are expressed in nanograms per milliliter (ng/mL). The table follows:
Immunoassay: The test must be calibrated with one analyte from the group identified as the target analyte. The cross-reactivity of the immunoassay to the other analyte(s) within the group must be 80 percent or greater; if not, separate immunoassays must be used for the analytes within the group.
3Alternate technology (THCA and Benzoylecgonine): When using an alternate technology initial test for the specific target analytes of THCA and Benzoylecgonine, the laboratory must use the same cutoff for the initial and confirmatory tests (i.e., 15 ng/mL for THCA and 100ng/mL for Benzoylecgonine).
Jon is a writer from California and now floats somewhere on an island in the Mediterranean. He thinks most issues can be solved by petting a good dog, and he spends plenty of time doing so. Time not spent at his desk is probably spent making art or entertaining humans or other animals.
Dr. Alan Carter is a clinical pharmacist with interests in medical research, pharmacy practice, and medication formulary management. He is an independent contracted medical director for pharmaceutical development, clinical pharmacy specialist, and adjunct clinical assistant professor of pharmacy.
Jamie is fascinated by the intersection of health and humanity. Before writing for Healthline, she completed a B.A. in English. She hopes her work will help increase health literacy and pave the way toward a healthy future for all. She is currently studying Public Health and Biostatistics.
Anna Smith Haghighi lives in Bangor, Northern Ireland, with her husband and their greyhounds Django and Zola. She found a passion for writing when creating content for various clients as part of an SEO company. Along the way, Anna has been a film and television extra, half of a singing duo, and a team member of the Belfast Eye. These days, Anna is more likely to be walking her dogs or playing a Zelda game for the millionth time.
Typically, traces of these substances in the urine mean the individual has these substances in their body. However, false positives can occur, where the test detects drugs when a person has not taken any.
Another important fact to note is that a 10-panel drug test will not tell if the person is currently on the drug. The tests measure byproducts in the body that come from breaking down the drug, so they cannot detect how much of the drug is circulating in the body.
If a company or organization requires a person to take a 10-panel drug test, they will generally give them notice of about 24 hours. Some professions may require the person to agree to random drug testing where they have little to no knowledge of the test beforehand.
The test environment may differ depending on who administers the test. Bathrooms are common locations, as these tests require urine. In some cases, the administrator may ask a person to use a particular bathroom stall to take the test.
If an administrator is concerned with contamination, they may take precautions such as turning off tap water in the bathroom or adding a dye to the toilet water. This can make the test more accurate and prevent tampering.
The test itself is straightforward. The person starts urinating and collects urine in the collection cup during the middle of their urine stream. They then close the container with the lid and give the sample to the test administrator.
When they receive the sample, the lab will test the urine for the 10 different drugs. Some tests offer onsite results that can analyze the urine samples straightaway. With that said, most samples will go to a lab for analysis, which can take a few days.
As the Substance Abuse and Mental Health Services Administration point out, federal employees and employees in many other safety fields have the right to have a second lab test their specimen if they receive a positive result. This precaution helps protect the individual from disciplinary action due to false positives.
A negative result indicates that the drugs tested for are not present or are not present in a high enough quantity to detect. It does not indicate that the person has never used the drugs or that they will not use the drugs in the future.
A 10-panel drug test is not the most common drug test. For instance, most employers who require testing will use a 4- or 5-panel drug test and an alcohol test. With that said, some professions involving personal and public safety may require regular 10-panel drug tests.
The DISA Global Solutions drug testing and alcohol testing combines technology and screening innovations to deliver employee information quickly and accurately. We specialize in giving employers the tools and information they need to make the most informed hiring decisions possible.
Whether that's a 5-panel, a 10-panel drug screen, DOT drug test, or something completely customized, DISA will take your drug testing program to the next level, regardless of your industry or unique requirements.
Our proprietary online platform advanced functionality has been developed and customized to meet the requirements of our unique and diverse client base. It gives each client the ability to track and manage sensitive program information in a highly secure, real-time environment with the convenience of online access. Check out how our software integration partners provide a better experience for customers and applicants.
By signing up for this email, you are agreeing to receive news, offers, and information from DISA Global Solutions.Click here to visit our Privacy Policy. Easy unsubscribe links are provided in every email.
Changes and New Tests Explore the most recent updates to our Laboratory Test Directory in one convenient location. Review important information about upcoming or current Hotlines, CPT code changes, new tests, and immediate activations.
Clinical and Academic Research Our Clinical Trials group supports a variety of research efforts, including academic research initiatives, and serves clients from central laboratories, clinical research organizations (CROs), in vitro device (IVD) manufacturers, and more. Discover all of our services.
Start Your Journey With ARUP Explore exciting career opportunities across a variety of fields and experience levels. Open positions are posted in one convenient location so you can easily find your perfect fit.
3a8082e126